RaeMR, ButlerRN, CampisiJ, de GreyADNJ, FinchCE, GoughM, MartinGM, VijgJ, PerrottKM, LoganBJ. The demographic and biomedical case for late-life interventions in aging. Science Translational Medicine, 2,40:21.
2.
de GreyADNJ. Man, machines, manufacturing, and maintenance: Merits of a much-maligned metaphor. Rejuvenation Res, 2008; 11:277–279.
3.
de GreyADNJ. Long live the unreasonable man. Rejuvenation Res, 2008; 11:541–542.
4.
de GreyADNJ. The Einsteinian imperative. Rejuvenation Res, 2009; 12:383–385.
5.
de GreyADNJ. The curiously misunderstood role of evidence in designing new technology. Rejuvenation Res, 2009; 12:75–76.
6.
PartridgeB, LuckeJ, BartlettH, HallW. Ethical, social, and personal implications of extended human lifespan identified by members of the public. Rejuvenation Res, 2009; 12:351–357.
7.
WarnerHR. Making the political case for biogerontology funding: A view from the trenches. Rejuvenation Res, 2008; 11:485–488.
8.
LedermanS. American Federation for Aging Research: Interview with Stephanie Lederman. Interview by Vicki Glaser. Rejuvenation Res, 2009; 12:155–157.
9.
ButlerRN. Interview with Robert Butler, M.D. Interview by Vicki Glaser. Rejuvenation Res, 2008; 11:977–980.
10.
JaenischR. Interview with Rudolf Jaenisch, M.D. Interview by Vicki Glaser. Rejuvenation Res, 2008; 11:849–850.
11.
BlackburnE. Interview with Elizabeth Blackburn, Ph.D. Interview by Vicki Glaser. Rejuvenation Res, 2008; 11:701–705.
12.
MillerRA, HarrisonDE, AstleCM, FloydRA, FlurkeyK, HensleyKL, JavorsMA, LeeuwenburghC, NelsonJF, OnginiE, NadonNL, WarnerHR, StrongR. An aging interventions testing program: Study design and interim report. Aging Cell, 2007; 6:565–575.
13.
HarrisonDE, StrongR, SharpZD, NelsonJF, AstleCM, FlurkeyK, NadonNL, WilkinsonJE, FrenkelK, CarterCS, PahorM, JavorsMA, FernandezE, MillerRA. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature, 2009; 460:392–395.
14.
BlagosklonnyMV. Aging, stem cells, and mammalian target of rapamycin: a prospect of pharmacologic rejuvenation of aging stem cells. Rejuvenation Res, 2008; 11:801–808.
15.
de GreyADNJ. Curiosity is addictive, and this is not an entirely good thing. Rejuvenation Res, 2008; 11:1–3.
16.
AbramovichA, MuradianKK, FraifeldVE. Have we reached the point for in vivo rejuvenation?Rejuvenation Res, 2008; 11:489–492.
17.
LeeSJ, Van DykeM, AtalaA, YooJJ. Host cell mobilization for in situ tissue regeneration. Rejuvenation Res, 2008; 11:747–756.
18.
KurzT. Can lipofuscin accumulation be prevented?Rejuvenation Res, 2008; 11:441–443.
19.
LeeSJ, Van DykeM, AtalaA, YooJJ. Host cell mobilization for in situ tissue regeneration. Rejuvenation Res, 2008; 11:747–756.
20.
OkarmaT. Interview with Thomas Okarma, M.D., Ph.D.; CEO, Geron. Interview by Vicki Glaser. Rejuvenation Res, 2009; 12:295–300. Interview with Thomas Okarma, M.D., Ph.D.; CEO, Geron. Interview by Vicki Glaser. Rejuvenation Res, 2009; 12:295–300.
21.
SinclairDA. Interview with David A. Sinclair, Ph.D. Interview by Vicki Glaser. Rejuvenation Res, 2008; 11:265–268.
22.
ChenJ, VelalarCN, RuanR. Identifying the changes in gene profiles regulating the amelioration of age-related oxidative damages in kidney tissue of rats by the intervention of adult-onset calorie restriction. Rejuvenation Res, 2008; 11:757–763.
23.
FroyO, ChapnikN, MiskinR. Relationship between calorie restriction and the biological clock: Lessons from long-lived transgenic mice. Rejuvenation Res, 2008; 11:467–471.
24.
GoertzelB, PennachinC, de Alvarenga MudadoM, de Souza CoelhoL. Identifying the genes and genetic interrelationships underlying the impact of calorie restriction on maximum lifespan: an artificial intelligence-based approach. Rejuvenation Res, 2008; 11:735–748.
25.
HipkissAR. On methionine restriction, suppression of mitochondrial dysfunction and aging. Rejuvenation Res, 2008; 11:685–688.
26.
HoferT, FontanaL, AntonSD, WeissEP, VillarealD, MalayappanB, LeeuwenburghC. Long-term effects of caloric restriction or exercise on DNA and RNA oxidation levels in white blood cells and urine in humans. Rejuvenation Res, 2008; 11:793–799.
27.
BrindleyD, DavieN. Regenerative medicine through a crisis: social perception and the financial reality. Rejuvenation Res, 2009; 12:455–461.